top of page
Vaccine Process Development and Scale-up
Application Deadline:
Call closed
Dates:
11-12 February 2025
Location:
Vienna, Austria
Contact:
Johannes Buyel
johannes.buyel@boku.ac.at
Provider:
BOKU University
Administrative support:
For questions about the application process, registration and scholarships: transvacinfo@euvaccine.eu
Registration fees
- €900 per person
Minimal requirements
Bachelor degree in natural sciences or engineering, ideally specialising in biology, biotechnology, chemical engineering or similar topics.
Who should apply
Recommended applicant profiles include:
• Scientists and engineers engaged in vaccine development who wish to advance their products from bench to manufacturing scale.
• Researchers (e.g. from product development) who wish to improve their ability to communicate with colleagues from process development.
• Supervisors who intend to deepen their understanding of bioprocesses to facilitate integration of different teams.
• Junior scientists (e.g. PhD students) looking to complete their education on bioprocess development.
Learning outcomes
Attendees will be able to explain the type and function of equipment necessary to build clean room environments for vaccine production. They will be able to describe the function and typical application of scalable bioprocess equipment including throughput, costs, etc.
Attendees will also be able to select suitable host organisms for vaccine production based on the vaccine properties and understand advantages and limitations of individual hosts. They will be able to design and compare different bioprocesses in terms of scalability, costs and complexity.
Course content
General strategies in process development for recombinant protein production and purification in different host systems with a special focus on state-of-the-art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification is presented.
Typical processes will be discussed using real-life equipment and examples. Specifically, we will first discuss (clean room) environments and the corresponding installations necessary to produce recombinant proteins under good manufacturing practice (GMP) conditions. Next, we will have a detailed look at typical bioprocess devices including individual advantages and drawbacks. Then, the potential organisms that can be used for manufacturing are compared focusing on product requirements. Lastly, we will discuss how all aspects can be combined to build scalable bioprocesses for vaccine manufacturing.
Overview
The options and requirements for vaccine process development are discussed focusing on (clean room) environments, devices, organisms and process concepts.
Scholarships
We are pleased to offer free registration and travel funding to selected researchers from low- and middle-income countries (LMICs). These registration and travel grants for LMIC applicants are generously sponsored by the Coalition for Epidemic Preparedness Innovations (CEPI).
Please note that not all courses are open for application submission, check open calls to know which for which courses you can apply for at the moment.
Be the first to know about the upcoming application calls, follow European Vaccine Initiative on X and LinkedIn or subscribe to EVI Newsletter.
bottom of page